4//SEC Filing
Graff Fred 4
Accession 0001123292-17-001465
CIK 0001588972other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:54 PM ET
Size
4.7 KB
Accession
0001123292-17-001465
Insider Transaction Report
Form 4
Graff Fred
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2017-09-28+2,000→ 10,000 total
Footnotes (1)
- [F1]On September 28, 2017, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 2,000 performance-based restricted stock units, which were converted into 2,000 shares of common stock on a one-for-one basis.
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeother
Related Parties
1- filerCIK 0001667407
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:54 PM ET
- Size
- 4.7 KB